These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
468 related items for PubMed ID: 17316439
21. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. Zupan J, Komadina R, Marc J. J Biomed Sci; 2012 Mar 01; 19(1):28. PubMed ID: 22380539 [Abstract] [Full Text] [Related]
22. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation. Ishida M, Amano S. J Bone Miner Metab; 2004 Mar 01; 22(5):415-29. PubMed ID: 15316862 [Abstract] [Full Text] [Related]
28. Facilitation of bone resorption activities in synovial lavage fluid patients with mandibular condyle fractures. Takano H, Takahashi T, Nakata A, Nogami S, Yusa K, Kuwajima S, Yamazaki M, Fukuda M. J Oral Rehabil; 2016 May 01; 43(5):333-9. PubMed ID: 26946239 [Abstract] [Full Text] [Related]
29. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. Michael H, Härkönen PL, Väänänen HK, Hentunen TA. J Bone Miner Res; 2005 Dec 01; 20(12):2224-32. PubMed ID: 16294275 [Abstract] [Full Text] [Related]
30. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity. Irie A, Takami M, Kubo H, Sekino-Suzuki N, Kasahara K, Sanai Y. Bone; 2007 Aug 01; 41(2):165-74. PubMed ID: 17560185 [Abstract] [Full Text] [Related]
31. IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts. Tanabe N, Maeno M, Suzuki N, Fujisaki K, Tanaka H, Ogiso B, Ito K. Life Sci; 2005 Jun 24; 77(6):615-26. PubMed ID: 15921993 [Abstract] [Full Text] [Related]
32. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro. Ming LG, Lv X, Ma XN, Ge BF, Zhen P, Song P, Zhou J, Ma HP, Xian CJ, Chen KM. Endocrinology; 2013 Mar 24; 154(3):1202-14. PubMed ID: 23389955 [Abstract] [Full Text] [Related]
34. Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells. Notoya M, Otsuka E, Yamaguchi A, Hagiwara H. Biochem Biophys Res Commun; 2004 Nov 12; 324(2):655-60. PubMed ID: 15474477 [Abstract] [Full Text] [Related]
36. Induction of osteoclast-like cells derived from the synovial lavage fluids of patients with temporomandibular joint disorders. Takano H, Ariyoshi W, Kanno T, Fukuhara E, Ichimiya H, Matayoshi T, Goto T, Takahashi T. Osteoarthritis Cartilage; 2007 Mar 12; 15(3):291-9. PubMed ID: 16979913 [Abstract] [Full Text] [Related]
37. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. Wang X, Wu J, Shidoji Y, Muto Y, Ohishi N, Yagi K, Ikegami S, Shinki T, Udagawa N, Suda T, Ishimi Y. J Bone Miner Res; 2002 Jan 12; 17(1):91-100. PubMed ID: 11771673 [Abstract] [Full Text] [Related]
38. Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis. Mediero A, Wilder T, Shah L, Cronstein BN. FASEB J; 2018 Jul 12; 32(7):3487-3501. PubMed ID: 29394106 [Abstract] [Full Text] [Related]
39. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K. Mandelin J, Li TF, Hukkanen M, Liljeström M, Salo J, Santavirta S, Konttinen YT. J Rheumatol; 2005 Apr 12; 32(4):713-20. PubMed ID: 15801030 [Abstract] [Full Text] [Related]